Haleon PLC (GB:HLN)
LSE:HLN
HLN Stock Chart & Stats
365.00 p
2.70 p(0.71%)
At close: 4:00 PM EST
365.00 p
2.70 p(0.71%)
Day’s Range― - ―
52-Week Range274.40 p - 419.50 p
Previous CloseN/A
Volume4.86M
Average Volume (3M)23.77M
Market Cap
£32.59B
Enterprise Value39.93B
Total Cash (Recent Filing)£676.00M
Total Debt (Recent Filing)£8.54B
Price to Earnings (P/E)―
Beta0.41
Next Earnings
Jul 30, 2026EPS Estimate
0.1Next Dividend Ex-DateN/A
Dividend Yield1.51%
Share Statistics
EPS (TTM)0.05
Shares Outstanding8,929,180,000
10 Day Avg. Volume25,018,353
30 Day Avg. Volume23,772,072
Financial Highlights & Ratios
PEG Ratio1.07
Price to Book (P/B)2.05
Price to Sales (P/S)3.05
P/FCF Ratio16.67
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
£426.45Price Target Upside16.84% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering11
EPS Forecast (FY)0.21
Revenue Forecast (FY)£11.40B
Bulls Say, Bears Say
Bulls Say
Core Sales MomentumUnderlying sales excluding cold and flu show growth, signaling improving core demand driven by stronger performance in the United States and emerging markets.
Margin ResilienceHealthy margins continue to support earnings per share, providing earnings resilience while top-line recovery is expected to progress.
Operating Profit GuidanceImproved operating profit guidance bolsters earnings expectations and reduces downside risk to reported profits, strengthening investor confidence in the recovery path.
Bears Say
Cold And Flu Sales ShortfallA significant shortfall in cold and flu sales weighed on reported results and acted as a material headwind to revenue growth.
Inventory Destocking In North AmericaOngoing inventory destocking in North America has left product shipments running flat, restraining near-term volume growth and limiting sales momentum.
Management Communication And GuidanceUnclear communication about the sales shortfall combined with weaker medium-term sales guidance could prompt a valuation reassessment by the market.
Haleon PLC News
HLN FAQ
What was Haleon PLC’s price range in the past 12 months?
Haleon PLC lowest share price was 274.40 p and its highest was 419.50 p in the past 12 months.
What is Haleon PLC’s market cap?
Haleon PLC’s market cap is £32.59B.
When is Haleon PLC’s upcoming earnings report date?
Haleon PLC’s upcoming earnings report date is Jul 30, 2026 which is in 124 days.
How were Haleon PLC’s earnings last quarter?
Haleon PLC released its earnings results on Feb 25, 2026. The company reported 0.048 p earnings per share for the quarter, beating the consensus estimate of 0.046 p by 0.002 p.
Is Haleon PLC overvalued?
According to Wall Street analysts Haleon PLC’s price is currently Undervalued.
Does Haleon PLC pay dividends?
Haleon PLC pays a Quarterly dividend of 2.2 p which represents an annual dividend yield of 1.51%. See more information on Haleon PLC dividends here
What is Haleon PLC’s EPS estimate?
Haleon PLC’s EPS estimate is 0.1.
How many shares outstanding does Haleon PLC have?
Haleon PLC has 8,929,180,000 shares outstanding.
What happened to Haleon PLC’s price movement after its last earnings report?
Haleon PLC reported an EPS of 0.048 p in its last earnings report, beating expectations of 0.046 p. Following the earnings report the stock price went down -6.852%.
Which hedge fund is a major shareholder of Haleon PLC?
Currently, no hedge funds are holding shares in GB:HLN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Haleon PLC Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
£426.45 (16.84% Upside)
£426.45 (16.84% Upside)
Blogger Sentiment
Bullish
GB:HLN Sentiment 100%
Sector Average 69%
Sector Average 69%
Insider Transactions
Sold Shares
Worth £2.8M over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-6.91%
12-Months-Change
Fundamentals
Return on Equity
9.44%
Trailing 12-Months
Asset Growth
-4.91%
Trailing 12-Months
Company Description
Haleon PLC
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom.
HLN Stock 12 Month Forecast
Average Price Target
426.45 p
▲(16.84% Upside)
Technical Analysis
Allergy Therapeutics
―
Provexis
―
Shield Therapeutics
―
Venture Life
―
Beximco Pharmaceuticals Limited Sponsored GDR RegS
―
Options Prices
Currently, No data available
---